Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Operating Expenses | 4,933 | 4,809 | 3,769 | 3,817 | 5,370 |
| Operating Income | -4,933 | -4,809 | -3,769 | -3,817 | -5,370 |
| Other Income | 51 | 57 | 46 | 26 | 15 |
| Pre-tax Income | -4,882 | -4,752 | -3,723 | -3,791 | -5,355 |
| Net Income Continuous | -4,882 | -4,752 | -3,723 | -3,791 | -5,355 |
| Net Income | $-4,882 | $-4,752 | $-3,723 | $-3,791 | $-5,355 |
| EPS Basic Total Ops | -14.77 | -14.41 | -13.21 | -16.81 | -24.61 |
| EPS Basic Continuous Ops | -14.73 | -14.46 | -13.10 | -17.02 | -24.86 |
| EPS Diluted Total Ops | -14.77 | -14.41 | -13.21 | -16.81 | -24.61 |
| EPS Diluted Continuous Ops | -14.73 | -14.46 | -13.10 | -17.02 | -24.86 |
| EBITDA(a) | $-4,931 | $-4,807 | $-3,768 | $-3,816 | $-5,369 |